Laboratory News and Research

RSS

A1C test for diagnosing diabetes must be reevaluated: Journal of Diabetes

As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers - who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.

5 Apr 2010

Diabetic tests must be regulated

As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.

5 Apr 2010

New report questions the kinetics of T cell receptors

T cell receptors are among the most important molecules in the immune system because of their role in recognizing the antigens that signal such threats as viruses and cancer. The receptors must also distinguish these threats from the body's own cells to avoid triggering an unwanted immune system response.

5 Apr 2010

BioCenter: Launch point for biomedical innovation in North Texas

BioCenter at Southwestern Medical District offers a springboard to drive biomedical innovation in North Texas to business operations, from earliest stage startups exploring bold new ideas to established companies needing an entire custom-designed floor to bring products to fruition.

3 Apr 2010

Sherwin-Williams Chemical Coatings forms partnership with Microban International

Sherwin-Williams Chemical Coatings Division is raising the bar for quality coatings by partnering with Microban International, the global leader in built-in antimicrobial protection, to offer select liquid and powder product finishes with Microban(R) antimicrobial protection. Microban(R) protection works continuously to inhibit the growth of bacteria that can cause stain, odor, discoloration and deterioration of the painted surface.

3 Apr 2010

Cancer research at Georgia Tech: Report

Cancer treatment typically involves surgery, radiation therapy, chemotherapy, hormone therapy or biological therapy. An oncologist may use one therapy or a combination of methods, depending on the type and location of the cancer, whether the disease has spread, the patient's age and general health, and other factors.

3 Apr 2010

Study could aid in developing new, effective treatments for prostate cancer

Van Andel Research Institute (VARI) scientists have determined how two proteins required for the initiation and development of prostate cancer interact at the molecular level, which could lead to improved treatments for the disease.

3 Apr 2010

Study uses hESC to derive floor plate tissue

New York Stem Cell Foundation (NYSCF) Fellow, Christopher Fasano, PhD, of the New York Neural Stem Cell Institute, is lead author on a study that investigating human neural development. Dr. Fasano conducted this work while working as a post-doctoral fellow at Memorial Sloan Kettering Cancer Center in the lab of Dr. Lorenz Studer.

3 Apr 2010

Kinetics of T cell receptors: New findings could lead to reevaluation of earlier conclusions

3 Apr 2010

Researchers explore microbial infection of human cells in space environment

In a first-of-its-kind experiment, the unique conditions of spaceflight will be used to examine how cells remain healthy or succumb to disease, particularly in the face of stress or damage.

3 Apr 2010

Harnessing body's own natural killer cells to battle cancer in children

Work underway at St. Jude Children's Research Hospital seeks to harnesses the body's own immune cells known as natural killer, or NK, cells to help children battle cancer. NK cells are the immune system's warriors. The cells circulate widely in the body, armed with proteins, called enzymes, capable of delivering a deadly one-two punch to viruses and cancer cells.

3 Apr 2010

New automated technology may help detect pathogens in food and water

Detecting one of the world's most common pathogens in drinking water soon may no longer be bottle-necked under a laboratory microscope.

3 Apr 2010

New production method yields hundredsfold more ubiquitylated proteins critical for cancer research

Scientists at the University of Delaware have developed a new method for producing proteins critical to research on cancer, Alzheimer's, and other diseases.

3 Apr 2010

Cellvax moves to new laboratory facility in ENVA

Cellvax is a French service company which provides complete in vitro & in vivo preclinical innovating services allowing to accelerate the drug development process for unmet needs related with severe human diseases, mainly in oncology field.

3 Apr 2010

Winner of 2010-2011 Luminex/ACMGF Award

The American College of Medical Genetics Foundation (ACMGF) has awarded Dr. Marilyn M. Li, of the Tulane Medical Center and the Tulane University School of Medicine the 2010-2011 Luminex/ACMGF Award at the ACMG 2010 Annual Clinical Genetics Meeting in Albuquerque, NM.

From Luminex 3 Apr 2010

Beike Biotechnology awarded ISO9001 certification for implementation of comprehensive QMS

Beike Biotechnology Co. Ltd., one of the world's leading biotechnology companies focusing on adult stem cell therapies, has been awarded ISO9001 certification by the International Organization for Standardization ("ISO"). This internationally recognized designation signifies Beike has established a Quality Management System (QMS) that complies with ISO9001 standards.

3 Apr 2010

DNA patent case: US District Judge rules in favor of AMP

The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.

2 Apr 2010

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

2 Apr 2010

Ontario Association of Medical Laboratories invites applications for 2010 Small Grants Program

The Ontario Association of Medical Laboratories is pleased to announce its 2010 Small Grants Program to support non-proprietary research projects to improve the efficiency or effectiveness of the delivery of laboratory services. Previously funded projects have included research into new testing methodologies, information systems and improvements to operational systems.

2 Apr 2010

Nanotechnology for eavesdropping on inner electrical activity of individual cells

A nanometer-scale probe designed to slip into a cell wall and fuse with it could offer researchers a portal for extended eavesdropping on the inner electrical activity of individual cells.

2 Apr 2010